Stephen Jensik to Graft Rejection
This is a "connection" page, showing publications Stephen Jensik has written about Graft Rejection.
Connection Strength
0.151
-
Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
Score: 0.151